Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Distler

Showing results (351-360 of 621) with videos related to

Pageof 63
Sort By:
Circulation Research|June 5, 2004
Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosisOliver Distler, Jörg H W Distler, Annette Scheid, et al.
Annals of the Rheumatic Diseases|January 20, 2012
Jun N-terminal kinase as a potential molecular target for prevention and treatment of dermal fibrosisNicole Reich, Michal Tomcik, Pawel Zerr, et al.
European Journal of Radiology|December 16, 2025
Automated lung texture analysis for assessing interstitial lung disease in systemic sclerosis: Diagnostic accuracy in photon-counting-detector and conventional energy-integrating-detector CTJasmin Happe, Cosimo Bruni, Lisa Jungblut, et al.
Journal of Scleroderma and Related Disorders|March 24, 2025
Interstitial lung disease in anti-U1RNP systemic sclerosis patients: A European Scleroderma Trials and Research analysisGonçalo Boleto, Corrado Campochiaro, Oliver Distler, et al.
Autoimmunity Reviews|February 6, 2023
The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohortAmalia Colalillo, Anna-Maria Hoffmann-Vold, Chiara Pellicano, et al.
RMD Open|January 10, 2024
Characteristics and disease course of untreated patients with interstitial lung disease associated with systemic sclerosis in a real-life two-centre cohortMoritz Scheidegger, Marouane Boubaya, Alexandru Garaiman, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 16, 2002
Physiologically low oxygen concentrations in fetal skin regulate hypoxia-inducible factor 1 and transforming growth factor-beta3Annette Scheid, Roland H Wenger, Leonhard Schäffer, et al.
Rheumatology (Oxford, England)|February 5, 2016
An EULAR study group pilot study on reliability of simple capillaroscopic definitions to describe capillary morphology in rheumatic diseasesVanessa Smith, Sam Beeckman, Ariane L Herrick, et al.
The Lancet. Rheumatology|January 30, 2024
Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS)Silvia Bellando-Randone, Francesco Del Galdo, Gemma Lepri, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 25, 2023
Endothelial Response to Type I Interferon Contributes to Vasculopathy and Fibrosis and Predicts Disease Progression of Systemic SclerosisHanlin Yin, Oliver Distler, Lichong Shen, et al.
Pageof 63

Showing results (351-360 of 621) with videos related to

Sort By:
Pageof 63
Circulation Research|June 5, 2004
Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosisOliver Distler, Jörg H W Distler, Annette Scheid, et al.
Annals of the Rheumatic Diseases|January 20, 2012
Jun N-terminal kinase as a potential molecular target for prevention and treatment of dermal fibrosisNicole Reich, Michal Tomcik, Pawel Zerr, et al.
European Journal of Radiology|December 16, 2025
Automated lung texture analysis for assessing interstitial lung disease in systemic sclerosis: Diagnostic accuracy in photon-counting-detector and conventional energy-integrating-detector CTJasmin Happe, Cosimo Bruni, Lisa Jungblut, et al.
Journal of Scleroderma and Related Disorders|March 24, 2025
Interstitial lung disease in anti-U1RNP systemic sclerosis patients: A European Scleroderma Trials and Research analysisGonçalo Boleto, Corrado Campochiaro, Oliver Distler, et al.
Autoimmunity Reviews|February 6, 2023
The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohortAmalia Colalillo, Anna-Maria Hoffmann-Vold, Chiara Pellicano, et al.
RMD Open|January 10, 2024
Characteristics and disease course of untreated patients with interstitial lung disease associated with systemic sclerosis in a real-life two-centre cohortMoritz Scheidegger, Marouane Boubaya, Alexandru Garaiman, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 16, 2002
Physiologically low oxygen concentrations in fetal skin regulate hypoxia-inducible factor 1 and transforming growth factor-beta3Annette Scheid, Roland H Wenger, Leonhard Schäffer, et al.
Rheumatology (Oxford, England)|February 5, 2016
An EULAR study group pilot study on reliability of simple capillaroscopic definitions to describe capillary morphology in rheumatic diseasesVanessa Smith, Sam Beeckman, Ariane L Herrick, et al.
The Lancet. Rheumatology|January 30, 2024
Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS)Silvia Bellando-Randone, Francesco Del Galdo, Gemma Lepri, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 25, 2023
Endothelial Response to Type I Interferon Contributes to Vasculopathy and Fibrosis and Predicts Disease Progression of Systemic SclerosisHanlin Yin, Oliver Distler, Lichong Shen, et al.
Pageof 63